Health related quality of life (HRQOL) measures in healthcare delivery system

Indian perspective

Research output: Contribution to journalReview article

Abstract

Health Related Quality of Life (HRQOL) studies are increasingly becoming common in developed countries to support product label claims. A large body of research is devoted to developing and validating HRQOL measures. Generic as well as disease specific instruments to measure HRQOL are developed. Development and utilization of HRQOL instruments increased during last decade with efforts to improve patient health and value of health care services. Physical, social and emotional impact of diseases and their impact on patients' lives are focus of the HRQOL studies. HRQOL, as a concept, differs from physiologic aspects of disease and has been recognized as important clinical outcome in studies that evaluates pharmaceutical agents, medical technology and healthcare. Regulatory agencies life Food and Drug Administration (FDA) and European Medicines Agency (EMEA) have accepted importance of HRQOL as valid measure in clinical trials to support product label claim. The use of HRQOL instruments have been predominantly confined to North America and Europe. Significant progress is not made regarding use of HRQOL instruments in designing health policy in developing countries, including India. It is important to know how patients view their health and what their expectations from the healthcare system are for designing appropriate health policy and its implementation, budget allocation and deployment of healthcare resources. India, with its vast population and increasing healthcare delivery challenges, should aim at creating infrastructure for carrying out HRQOL studies and use of Patient Reported Outcome (PRO) instruments in making and implementing health policy decisions.

Original languageEnglish
Pages (from-to)164-167
Number of pages4
JournalJournal of Young Pharmacists
Volume8
Issue number3
DOIs
Publication statusPublished - 01-07-2016

Fingerprint

Quality of Life
Delivery of Health Care
Health Policy
India
Health
Budgets
United States Food and Drug Administration
North America
Developed Countries
Developing Countries
Health Services
Outcome Assessment (Health Care)
Clinical Trials
Technology
Research
Pharmaceutical Preparations
Population

All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

@article{6daa3ceb930c48018237cd04ae79cf64,
title = "Health related quality of life (HRQOL) measures in healthcare delivery system: Indian perspective",
abstract = "Health Related Quality of Life (HRQOL) studies are increasingly becoming common in developed countries to support product label claims. A large body of research is devoted to developing and validating HRQOL measures. Generic as well as disease specific instruments to measure HRQOL are developed. Development and utilization of HRQOL instruments increased during last decade with efforts to improve patient health and value of health care services. Physical, social and emotional impact of diseases and their impact on patients' lives are focus of the HRQOL studies. HRQOL, as a concept, differs from physiologic aspects of disease and has been recognized as important clinical outcome in studies that evaluates pharmaceutical agents, medical technology and healthcare. Regulatory agencies life Food and Drug Administration (FDA) and European Medicines Agency (EMEA) have accepted importance of HRQOL as valid measure in clinical trials to support product label claim. The use of HRQOL instruments have been predominantly confined to North America and Europe. Significant progress is not made regarding use of HRQOL instruments in designing health policy in developing countries, including India. It is important to know how patients view their health and what their expectations from the healthcare system are for designing appropriate health policy and its implementation, budget allocation and deployment of healthcare resources. India, with its vast population and increasing healthcare delivery challenges, should aim at creating infrastructure for carrying out HRQOL studies and use of Patient Reported Outcome (PRO) instruments in making and implementing health policy decisions.",
author = "Janodia, {Manthan Dilipkumar}",
year = "2016",
month = "7",
day = "1",
doi = "10.5530/jyp.2016.3.1",
language = "English",
volume = "8",
pages = "164--167",
journal = "Journal of Young Pharmacists",
issn = "0975-1483",
publisher = "E-Flow Medknow Publications",
number = "3",

}

Health related quality of life (HRQOL) measures in healthcare delivery system : Indian perspective. / Janodia, Manthan Dilipkumar.

In: Journal of Young Pharmacists, Vol. 8, No. 3, 01.07.2016, p. 164-167.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Health related quality of life (HRQOL) measures in healthcare delivery system

T2 - Indian perspective

AU - Janodia, Manthan Dilipkumar

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Health Related Quality of Life (HRQOL) studies are increasingly becoming common in developed countries to support product label claims. A large body of research is devoted to developing and validating HRQOL measures. Generic as well as disease specific instruments to measure HRQOL are developed. Development and utilization of HRQOL instruments increased during last decade with efforts to improve patient health and value of health care services. Physical, social and emotional impact of diseases and their impact on patients' lives are focus of the HRQOL studies. HRQOL, as a concept, differs from physiologic aspects of disease and has been recognized as important clinical outcome in studies that evaluates pharmaceutical agents, medical technology and healthcare. Regulatory agencies life Food and Drug Administration (FDA) and European Medicines Agency (EMEA) have accepted importance of HRQOL as valid measure in clinical trials to support product label claim. The use of HRQOL instruments have been predominantly confined to North America and Europe. Significant progress is not made regarding use of HRQOL instruments in designing health policy in developing countries, including India. It is important to know how patients view their health and what their expectations from the healthcare system are for designing appropriate health policy and its implementation, budget allocation and deployment of healthcare resources. India, with its vast population and increasing healthcare delivery challenges, should aim at creating infrastructure for carrying out HRQOL studies and use of Patient Reported Outcome (PRO) instruments in making and implementing health policy decisions.

AB - Health Related Quality of Life (HRQOL) studies are increasingly becoming common in developed countries to support product label claims. A large body of research is devoted to developing and validating HRQOL measures. Generic as well as disease specific instruments to measure HRQOL are developed. Development and utilization of HRQOL instruments increased during last decade with efforts to improve patient health and value of health care services. Physical, social and emotional impact of diseases and their impact on patients' lives are focus of the HRQOL studies. HRQOL, as a concept, differs from physiologic aspects of disease and has been recognized as important clinical outcome in studies that evaluates pharmaceutical agents, medical technology and healthcare. Regulatory agencies life Food and Drug Administration (FDA) and European Medicines Agency (EMEA) have accepted importance of HRQOL as valid measure in clinical trials to support product label claim. The use of HRQOL instruments have been predominantly confined to North America and Europe. Significant progress is not made regarding use of HRQOL instruments in designing health policy in developing countries, including India. It is important to know how patients view their health and what their expectations from the healthcare system are for designing appropriate health policy and its implementation, budget allocation and deployment of healthcare resources. India, with its vast population and increasing healthcare delivery challenges, should aim at creating infrastructure for carrying out HRQOL studies and use of Patient Reported Outcome (PRO) instruments in making and implementing health policy decisions.

UR - http://www.scopus.com/inward/record.url?scp=84973097267&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973097267&partnerID=8YFLogxK

U2 - 10.5530/jyp.2016.3.1

DO - 10.5530/jyp.2016.3.1

M3 - Review article

VL - 8

SP - 164

EP - 167

JO - Journal of Young Pharmacists

JF - Journal of Young Pharmacists

SN - 0975-1483

IS - 3

ER -